bluebird bio

PsiOxus and bluebird bio recently presented novel data combining PsiOxus’ T-SIGn platform with bluebird bio’s CAR-T therapy to clear primary tumors and metastases. Click here to find out more.


Sign up to our mailing list

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu